Skip to main content
Erschienen in: Clinical Oral Investigations 7/2022

14.04.2022 | Original Article

Evaluation of salivary and serum methylated arginine metabolites and nitric oxide synthase in advanced periodontitis patients

verfasst von: Volkan Şengül, Zeliha Güney, Şivge Kurgan, Canan Önder, Muhittin A. Serdar, Meral Günhan

Erschienen in: Clinical Oral Investigations | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Methylated arginine metabolites and nitric oxide synthase (NOS) play a critical role in regulating endothelial function. The aim of this study was to determine levels of NOS, and methylated arginine metabolites (ADMA, SDMA, homoarginine, arginine, and L-NMMA) and IL-6 in serum and saliva in patients with advanced periodontal diseases and identify their association with clinical parameters.

Materials and methods

The study consisted of two groups: healthy individuals (control: n = 24), and generalized Stage III Grade B periodontitis (P: n = 21). Clinical periodontal parameters (probing pocket depth, bleeding on probing, clinical attachment level) were recorded. IL 6 and NOS levels in saliva and serum were analyzed by enzyme-linked immunosorbent assay (ELISA). ADMA, SDMA, homoArg, arginine, and L-NMMA in saliva and serum were analyzed by liquid chromatography–mass spectrometry (LC MS/MS).

Results

Clinical parameters were significantly higher in the periodontitis group (p < 0.001). In periodontitis group, NOS, ADMA, and arginine levels in saliva were statistically significantly higher than control group (p < 0.05). Serum levels of SDMA were statistically significantly lower, and IL-6 was statistically significantly higher in P group than C group (p < 0.05). ADMA, NOS, and arginine levels were significantly positive correlated with all clinical periodontal parameters (p < 0.05).

Conclusions

These findings suggest that there is a relationship between severity of periodontal disease and endothelial dysfunction by means of ADMA. Salivary ADMA may be related with periodontal inflammation.

Clinical relevance

ADMA levels in periodontal inflammation are associated with endothelial dysfunction. According to the results of our study, periodontal inflammation is effective on both local and systemic methylated arginine metabolites and nitric oxide synthase levels. This may shed light on the relationship between periodontal disease and systemic status.
Fußnoten
1
William’s probe, Hu-Friedy, Chicago, IL.
 
2
Human IL-6 ELISA Kit, Uscn, Cloud-Clone Corp, USA and Human NOS1 ELISA Kit, Uscn, Cloud-Clone Corp, USA.
 
3
Synergy HT Microplate Reader, Bio-Tek Instruments, Winooski, WT, USA.
 
4
TSQ Quantum Access MAX Triple Stage Quadrupole Mass, Thermo Scientific, USA.
 
6
SPSS for Windows v.26, IBM SPSS Inc., New York, NY, USA.
 
Literatur
2.
Zurück zum Zitat Moncada S, Palmer RM, Higgs E (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43(2):109–142PubMed Moncada S, Palmer RM, Higgs E (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43(2):109–142PubMed
13.
Zurück zum Zitat Moura MF, Navarro TP, Silva TA, Cota LOM, Soares Dutra Oliveira AM, Costa FO (2017) Periodontitis and endothelial dysfunction: periodontal clinical parameters and levels of salivary markers interleukin-1β, tumor necrosis factor-α, matrix metalloproteinase-2, tissue inhibitor of metalloproteinases-2 complex, and nitric oxide. J Periodontol 88(8):778–787. https://doi.org/10.1902/jop.2017.170023CrossRefPubMed Moura MF, Navarro TP, Silva TA, Cota LOM, Soares Dutra Oliveira AM, Costa FO (2017) Periodontitis and endothelial dysfunction: periodontal clinical parameters and levels of salivary markers interleukin-1β, tumor necrosis factor-α, matrix metalloproteinase-2, tissue inhibitor of metalloproteinases-2 complex, and nitric oxide. J Periodontol 88(8):778–787. https://​doi.​org/​10.​1902/​jop.​2017.​170023CrossRefPubMed
17.
Zurück zum Zitat Isola G, Alibrandi A, Currò M, Matarese M, Ricca S, Matarese G, Ientile R, Kocher T (2020) Evaluation of salivary and serum ADMA levels in patients with periodontal and cardiovascular disease as subclinical marker of cardiovascular risk. J Periodontol. https://doi.org/10.1002/JPER.19-0446. Online ahead of print. Isola G, Alibrandi A, Currò M, Matarese M, Ricca S, Matarese G, Ientile R, Kocher T (2020) Evaluation of salivary and serum ADMA levels in patients with periodontal and cardiovascular disease as subclinical marker of cardiovascular risk. J Periodontol. https://​doi.​org/​10.​1002/​JPER.​19-0446. Online ahead of print.
24.
Zurück zum Zitat Di Gangi IM, Chiandetti L, Gucciardi A, Moret V, Naturale M, Giordano G (2010) Simultaneous quantitative determination of N(G), N(G)-dimethyl-L-arginine or asymmetric dimethylarginine and related pathway’s metabolites in biological fluids by ultrahigh-performance liquid chromatography/electrospray ionization-tandem mass spectrometry. Anal Chim Acta 677(2):140–148. https://doi.org/10.1016/j.aca.2010.08.011CrossRefPubMed Di Gangi IM, Chiandetti L, Gucciardi A, Moret V, Naturale M, Giordano G (2010) Simultaneous quantitative determination of N(G), N(G)-dimethyl-L-arginine or asymmetric dimethylarginine and related pathway’s metabolites in biological fluids by ultrahigh-performance liquid chromatography/electrospray ionization-tandem mass spectrometry. Anal Chim Acta 677(2):140–148. https://​doi.​org/​10.​1016/​j.​aca.​2010.​08.​011CrossRefPubMed
31.
Zurück zum Zitat Krzystek-Korpacka M, Wisniewski J, Fleszar FG, Bednarz-Misa I, Bronowicka-Szydełko A, Gacka M, Masłowski L, Kędzior K, Witkiewicz W (2019) Gamian A (2019) Metabolites of the NO pathway are altered and indicative of reduced NO and arginine bioavailability in patients with cardiometabolic diseases complicated with chronic wounds of lower extremities: targeted metabolomics approach. Oxid Med Cell Longev 2019:5965721. https://doi.org/10.1155/2019/5965721.eCollectionCrossRefPubMedPubMedCentral Krzystek-Korpacka M, Wisniewski J, Fleszar FG, Bednarz-Misa I, Bronowicka-Szydełko A, Gacka M, Masłowski L, Kędzior K, Witkiewicz W (2019) Gamian A (2019) Metabolites of the NO pathway are altered and indicative of reduced NO and arginine bioavailability in patients with cardiometabolic diseases complicated with chronic wounds of lower extremities: targeted metabolomics approach. Oxid Med Cell Longev 2019:5965721. https://​doi.​org/​10.​1155/​2019/​5965721.​eCollectionCrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Antoniades C, Tousoulis D, Marinou K, Vasiliadou C, Tentolouris C, Bouras G, Pitsavos C, Stefanadis C (2006) Asymmetrical dimethylarginine regulates endothelial function in methionine-induced but not in chronic homocystinemia in humans: effect of oxidative stress and proinflammatory cytokines. Am J Clin Nutr 84(4):781–788. https://doi.org/10.1093/ajcn/84.4.781CrossRefPubMed Antoniades C, Tousoulis D, Marinou K, Vasiliadou C, Tentolouris C, Bouras G, Pitsavos C, Stefanadis C (2006) Asymmetrical dimethylarginine regulates endothelial function in methionine-induced but not in chronic homocystinemia in humans: effect of oxidative stress and proinflammatory cytokines. Am J Clin Nutr 84(4):781–788. https://​doi.​org/​10.​1093/​ajcn/​84.​4.​781CrossRefPubMed
52.
Zurück zum Zitat Emrich IE, Zawada AM, Martens- Lobenhoffer J, Fliser D, Wagenpfeil S, Heine GH, Bode-Böger SM (2017) Symmetric dimethylarginine (SDMA) outperforms ADMA and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease. Clin Res Cardiol 107(3):201–213. https://doi.org/10.1007/s00392-017-1172-4CrossRefPubMed Emrich IE, Zawada AM, Martens- Lobenhoffer J, Fliser D, Wagenpfeil S, Heine GH, Bode-Böger SM (2017) Symmetric dimethylarginine (SDMA) outperforms ADMA and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease. Clin Res Cardiol 107(3):201–213. https://​doi.​org/​10.​1007/​s00392-017-1172-4CrossRefPubMed
Metadaten
Titel
Evaluation of salivary and serum methylated arginine metabolites and nitric oxide synthase in advanced periodontitis patients
verfasst von
Volkan Şengül
Zeliha Güney
Şivge Kurgan
Canan Önder
Muhittin A. Serdar
Meral Günhan
Publikationsdatum
14.04.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 7/2022
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-022-04479-w

Weitere Artikel der Ausgabe 7/2022

Clinical Oral Investigations 7/2022 Zur Ausgabe

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

08.04.2024 Zahnmedizin Nachrichten

Der Aufbau von Geweben und Organen während der Embryonalentwicklung wird von den Zellen bemerkenswert choreografiert. Für diesen Prozess braucht es spezielle sogenannte „Organisatoren“. In einer aktuellen Veröffentlichung im Fachjournal Nature Cell Biology berichten Forschende durch welchen Vorgang diese Organisatoren im Gewebe entstehen und wie sie dann die Bildung von Zähnen orchestrieren.

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.